About the Job
LOCATION: This territory covers the Carolinas and the Mid-Atlantic region, including North Carolina, South Carolina, Maryland, Virginia, West Virginia, and portions of Pennsylvania. Frequent travel throughout the territory is required.
Join Natera's Gynecologic Oncology Histology specialty team as a Clinical Oncology Specialist (COS), where you'll help expand access to innovative MRD testing for patients with gynecologic cancers. In this high-impact, field-based role, you will drive the adoption and growth of Signatera, Natera's personalized MRD c...
As a trusted clinical and commercial partner, you will build strategic relationships with key stakeholders across academic medical centers, integrated delivery networks, hospital systems, and community oncology practices. Working collaboratively with internal partners, you will expand access to Signatera by partneri...
Key Responsibilities
Develop expertise in Natera's oncology portfolio, clinical data, reimbursement landscape, competitive positioning, and internal processes.
Identify and develop relationships with Key Opinion Leaders (KOLs), academic medical centers, hospital systems, and community oncology practices to drive adoption of Natera's oncology portfolio.
Engage GYN oncologists and other healthcare professionals through consultative, clinical discussions that support the adoption of Natera's oncology diagnostics.
Develop and execute strategic territory plans to identify growth opportunities and influence key clinical and administrative stakeholders.
Achieve sales objectives and drive growth within the assigned territory.
Maintain accurate territory activity, customer insights, and sales forecasts while identifying risks and new business opportunities.
Conduct all business activities with integrity while maintaining compliance with company policies and industry regulations.
Perform other duties as assigned.
Required Skills & Abilities
Bachelor's degree required.
5+ years of successful medical sales experience, preferably within GYN Oncology, GYN Surgical Oncology, molecular diagnostics, or precision medicine.
Strong understanding of the academic and community oncology landscape, including molecular diagnostics, precision medicine, and reimbursement.
Experience calling on GYN Oncologists, GYN ONC Surgeons, Medical Oncologists, or other GYN oncology stakeholders preferred.
Demonstrated leadership, business acumen, financial management, and strong written and verbal communication skills.
Ability and willingness to travel overnight as needed.
Excellent written, verbal, presentation, and interpersonal communication skills.
Ability to communicate complex clinical and scientific information to physicians, multidisciplinary care teams, and executive stakeholders.
Ability to build trusted relationships and influence physicians, key opinion leaders, and multidisciplinary healthcare teams.
Strategic thinker with strong business acumen and the ability to develop and execute territory growth strategies.
Strong analytical, organizational, and problem-solving skills with the ability to manage multiple priorities in a dynamic environment.
Demonstrated ability to work independently while collaborating effectively across cross-functional teams.
Knowledge of oncology market dynamics, molecular diagnostics, precision medicine, and healthcare reimbursement is preferred.
You'll join a collaborative, high-performing oncology team dedicated to expanding access to innovative molecular diagnostics that help clinicians make more informed treatment decisions throughout the cancer journey.
At Natera, you'll have the opportunity to:
Represent one of the industry's most innovative molecular diagnostics portfolios, helping redefine how cancer is monitored and managed.
Build relationships with nationally recognized physicians, academic medical centers, and leading health systems at the forefront of precision oncology.
Join a collaborative culture that values innovation, accountability, and professional growth.
Make a meaningful impact on patients and the future of precision oncology.
